FDA orders immediate re-formulation of alcoholic energy drinks

The Food and Drugs Authority (FDA) has directed manufacturers to immediately re-formulate mixed drinks containing both alcohol and stimulants, citing public health concerns.

The directive follows a post-registration review of these products, which include stimulants such as caffeine, inositol, glucuronolactone, ginseng, and guarana. The FDA’s assessment considered international and regional regulatory actions, noting that several countries have restricted, suspended, or banned alcoholic energy drinks due to associated health risks.

The review was conducted under Sections 81 and 82(a) of the Public Health Act, 2012 (Act 851), which empowers the FDA to enforce standards necessary to protect public health and safety. It evaluated the safety and regulatory compliance of these products on the Ghanaian market and identified significant concerns over their combined effects.

“This review has shown growing scientific and public health evidence linking mixed drinks containing alcohol and stimulants to adverse health effects,” the FDA stated. “Manufacturers and producers are required to re-formulate their products to conform strictly to the approved standards for Alcoholic Beverages and Energy Drinks as separate product categories.”

The Authority emphasized that the directive takes effect immediately. All manufacturers and producers are expected to ensure that their products meet approved safety, quality, and regulatory standards without delay. Failure to comply may result in enforcement actions, including withdrawal of non-compliant products from the market.

The FDA also called on consumers to remain vigilant. “Consumers are encouraged to report any suspicious or non-compliant products to the FDA for investigation and enforcement action,” the notice added. The Authority said it will continue monitoring the market to ensure compliance and safeguard public health.

In addition to enforcement, the FDA reaffirmed its commitment to ensuring that all food and beverage products on the Ghanaian market are safe for consumption. Manufacturers, distributors, and retailers are expected to adhere strictly to the approved guidelines, while consumers are urged to be aware of product contents and report any concerns.

For further inquiries or concerns, stakeholders are advised to contact the FDA directly through its official channels. The directive underscores the Authority’s proactive role in protecting public health and maintaining regulatory standards for food and beverages in Ghana.